• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BioXcel Therapeutics, Inc. - Common Stock (NQ:BTAI)

1.840 -0.070 (-3.66%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about BioXcel Therapeutics, Inc. - Common Stock

< Previous 1 2 3 Next >
News headline image
Halper Sadeh LLC Encourages BioXcel Therapeutics, Inc. Shareholders to Contact the Firm to Discuss Their Rights
January 15, 2026
From Halper Sadeh LLC
Via Business Wire
News headline image
Halper Sadeh LLC Encourages BioXcel Therapeutics, Inc. Shareholders to Contact the Firm to Discuss Their Rights
October 24, 2025
From Halper Sadeh LLC
Via Business Wire
News headline image
Synergy Corp. (NASDAQ: SNYR) 1,600+ Nationwide Store Rollout – PPCB, SNGX, BTAI, HIT + Other Disruptive Stocks Moving Now!
August 18, 2025
Via AB Newswire
Topics Artificial Intelligence
News headline image
Avant Technologies and Ainnova Tech Announce Enhanced Patient Recruitment Strategy Ahead of FDA Clinical Trial
August 12, 2025
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:RXRX),(NASDAQ:RLYB),(NASDAQ:BTAI),(NYSE:PFE) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
News headline image
Synergy Inc. (NASDAQ: SNYR) CEO on Air Spotlights on FOCUSfactor® Legacy, Energy Beverage & Weight Loss – Poised for Explosive Growth – More Stocks Inside
August 06, 2025
Via AB Newswire
News headline image
Real-World Deployments Signal AI Healthcare Is Ready for Scale
May 30, 2025
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:TEM),(NASDAQ:BTAI),(OTCPK:HWAIF),(OTCQX:WHTCF) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
News headline image
The Next Wave of Health AI: Analysts Highlight Breakthroughs in Clinical Trials and Patient Care
December 17, 2024
USA News Group Commentary Issued on behalf of Avant Technologies Inc. Vancouver, BC – December 17, 2024 – USA News Group News Commentary – Artificial intelligence (AI) is on the brink of becoming a... 
Via FinancialNewsMedia
Topics Artificial Intelligence
Leading The Charge: Tonix Pharmaceuticals And The Future Of CNS Therapeutics
February 13, 2024
Via Get News
News headline image
BIOXCEL ALERT: Bragar Eagel & Squire, P.C. is Investigating BioXcel Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
February 09, 2024
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Anal Cancer Treatment Market Expected to Reach $1.63 Billion by 2030 as Latest Clinical Studies Focus on New Therapies
February 14, 2024
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:EXEL),(NYSE:PFE),(NASDAQ:BTAI),(NYSE:BMY) EQNX::TICKER_END 
Via FinancialNewsMedia
BioXcel Therapeutics, Inc. (NASDAQ:BTAI) Long Term Investor Notice: Investigation of Potential Wrongdoing ↗
December 08, 2023
San Diego, CA -- (SBWIRE) -- 12/08/2023 -- An investigation on behalf of current long-term investors in shares of BioXcel Therapeutics, Inc. (NASDAQ:BTAI) concerning potential breaches of fiduciary... 
Via SBWire
News headline image
Unlocking AI investment opportunities in healthcare
November 16, 2023
AI is revolutionizing healthcare by improving diagnosis and accelerating drug discovery. An often-overlooked sector with a wealth of AI opportunities. 
Via MarketBeat
Topics Artificial Intelligence ETFs
News headline image
Anal Cancer Treatment Market Expected to Reach $1.63 Billion by 2030 as Latest Clinical Studies Focus on New Therapies
February 14, 2024
From FN Media Group LLC
Via GlobeNewswire
BioXcel Therapeutics Inc. (NASDAQ: BTAI) Leading the Way in Wednesday Trading Based on Percentage Gain
October 25, 2023
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
BIOXCEL ALERT: Bragar Eagel & Squire, P.C. is Investigating BioXcel Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
October 11, 2023
From Bragar Eagel & Squire, P.C.
Via Business Wire
NASDAQ: BTAI Investor Alert: Deadline on September 5, 2023 in Lawsuit Against BioXcel Therapeutics, Inc. ↗
September 05, 2023
San Diego, CA -- (SBWIRE) -- 09/05/2023 -- The Shareholders Foundation announced that a deadline is coming up on September 5, 2023 in the lawsuit filed for certain investors of BioXcel Therapeutics,... 
Via SBWire
Topics Lawsuit
News headline image
BTAI DEADLINE TOMORROW: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages BioXcel Therapeutics, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important September 5 Deadline in Securities Class Action – BTAI
September 04, 2023
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
BTAI DEADLINE ALERT: ROSEN, A LONGSTANDING LAW FIRM, Encourages BioXcel Therapeutics, Inc. Investors With Losses to Secure Counsel Before Important September 5 Deadline in Securities Class Action - BTAI
September 03, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
BIOXCEL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against BioXcel Therapeutics, Inc. and Encourages Investors to Contact the Firm
September 01, 2023
From Bragar Eagel & Squire, P.C.
Via Business Wire
News headline image
BIOXCEL 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against BioXcel Therapeutics, Inc. - BTAI
September 01, 2023
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against BioXcel Therapeutics, Inc. (BTAI)
September 01, 2023
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
4-DAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in BioXcel Therapeutics, Inc. with Losses of $100,000 to Contact the Firm
September 01, 2023
Via ACCESSWIRE
News headline image
BIOXCEL THERAPEUTICS, INC. (NASDAQ: BTAI) SHAREHOLDER ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against BioXcel Therapeutics, Inc.
August 29, 2023
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages BioXcel Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important September 5 Deadline in Securities Class Action - BTAI
August 28, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against BioXcel, Seagate, and Baxter and Encourages Investors to Contact the Firm
August 27, 2023
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
ROSEN, A RESPECTED AND LEADING FIRM, Encourages BioXcel Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important September 5 Deadline in Securities Class Action - BTAI
August 27, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
ROSEN, A LEADING AND TOP RANKED LAW FIRM, Encourages BioXcel Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important September 5 Deadline in Securities Class Action – BTAI
August 26, 2023
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
BioXcel Therapeutics, Inc. Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds BTAI Investors of Securities Fraud Class Action Lawsuit Filed On Their Behalf
August 23, 2023
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
News headline image
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages BioXcel Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BTAI
August 22, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
BIOXCEL THERAPEUTICS, INC. (NASDAQ: BTAI) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against BioXcel Therapeutics, Inc.
August 22, 2023
From Bernstein Liebhard LLP
Via GlobeNewswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap